Cargando…
Exploratory Profiling of Urine MicroRNAs in the dy(2J)/dy(2J) Mouse Model of LAMA2-CMD: Relation to Disease Progression
Circulating microRNAs (miRNAs) are being considered as non-invasive biomarkers for disease progression and clinical trials. Congenital muscular dystrophy with deficiency of laminin α2 chain (LAMA2-CMD) is a very severe form of muscular dystrophy, for which no treatment is available. In order to iden...
Autores principales: | Moreira Soares Oliveira, Bernardo, Gawlik, Kinga I, Durbeej, Madeleine, Holmberg, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140833/ https://www.ncbi.nlm.nih.gov/pubmed/30430039 http://dx.doi.org/10.1371/currents.md.d0c203c018bc024f2f4c9791ecb05f88 |
Ejemplares similares
-
Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD
por: Moreira Soares Oliveira, Bernardo, et al.
Publicado: (2017) -
Antioxidants Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
por: Harandi, Vahid M., et al.
Publicado: (2020) -
A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD
por: Gawlik, Kinga I., et al.
Publicado: (2020) -
Bortezomib Does Not Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
por: Körner, Zandra, et al.
Publicado: (2016) -
Early skeletal muscle pathology and disease progress in the dy(3K)/dy(3K) mouse model of congenital muscular dystrophy with laminin α2 chain-deficiency
por: Gawlik, Kinga I., et al.
Publicado: (2019)